Combining Rituximab with Belimumab in Severe Lupus

Our next #RheumJC session will be Thursday, April 26th at 9pm Eastern Time / 8pm Central Time (click here to find this in your local time zone).

We’ll be discussing the recent Journal of Autoimmunity article: The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Cardiovascular Safety of Febuxostat or Allopurinol

Our next #RheumJC session will be Thursday, March 29th at 9pm Eastern Time / 8pm Central Time (click here to find this in your local time zone).

We’ll be discussing the recent New England Journal of Medicine article: Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Abatacept for Treatment of RA-ILD

Our next #RheumJC session will be Thursday, February 22nd at 9pm Eastern Time / 8pm Central Time (click here to find this in your local time zone).

We’ll be discussing the recent Seminars in Arthritis & Rheumatism article: Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Stem-Cell Transplantation for Scleroderma

Our next #RheumJC session will be Thursday, January 25th at 9pm Eastern Time / 8pm Central Time (click here to find this in your local time zone).

We’ll be discussing the recent New England Journal of Medicine Article: Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Favorite Abstracts from the 2017 ACR Annual Meeting

Our next #RheumJC session will be Thursday, November 30th at 10pm Eastern Time (click here to find this in your time zone).

We’ll be discussing four of our favorite abstracts from the recent #ACR17 Meeting in San Diego:

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis

Our next #RheumJC session will be Thursday, October 26th.

We’ll be discussing the article Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis epublished in Arthritis Care & Research

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Role of Blocking IL-1 with Canakinumab for Atherosclerotic Disease

Update 09/29/2017: Here is a Storify summary of our session: https://storify.com/psufka/rheumjc-from-09-28-2017 

Our next #RheumJC session will be Thursday, September 28th.

We’ll be discussing the recently published NEJM article Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Also refer to the associated editorial in NEJM, Targeting Inflammation in Coronary Artery Disease.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Guidelines on Perioperative Management of Antirheumatic Medication for Hip & Knee Arthroplasty

After a brief summer break, #RheumJC is back!

Our next session will be Thursday, July 27th, discussing the recently published guidelines in Arthritis Care & Research: 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Effect of methotrexate discontinuation on efficacy of influenza vaccination in RA

This week’s #RheumJC will be Thursday, May 25th, discussing the May 2017 Annals of the Rheumatic Diseases article: Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial by Dr. Jin Kyun Park, et al.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Spinal Manipulation in the Treatment of Low Back Pain

Our next #RheumJC discussion will be Thursday, April 27th, discussing the April 2017 JAMA article: Association of Spinal Manipulative Therapy With Clinical Benefit and Harm for Acute Low Back Pain: Systematic Review and Meta-analysis by Dr. Neil M. Paige, et al.

The publisher has graciously made this article free to access on April 26–27.

We also suggest the accompanying editorial: The Role of Spinal Manipulation in the Treatment of Low Back Pain.

Please note, our second session will be held one hour earlier than our usual time.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

  1. Please remember to try to stay on topic whenever possible.
  2. Be polite and courteous.
  3. Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.